MedPath

Hyaluronic Acid

Approved
Approval ID

a75e2bb2-f89a-53f4-e053-2a95a90a93c7

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jun 5, 2020

Manufacturers
FDA

Quimfa S.A

DUNS: 955064287

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Hyaluronic Acid

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code77651-4162
Application NumberANDA076559
Product Classification
M
Marketing Category
C73584
G
Generic Name
Hyaluronic Acid
Product Specifications
Route of AdministrationINTRAEPIDERMAL
Effective DateJune 5, 2020
FDA Product Classification

INGREDIENTS (1)

HYALURONIC ACIDActive
Quantity: 2.5 g in 1 1
Code: S270N0TRQY
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Hyaluronic Acid - FDA Drug Approval Details